Sinclair Pharma Plc (SPH)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Sinclair Pharma Plc (SPH)-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH80664D
  • |
  • Pages: 43
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Sinclair Pharma plc (Sinclair), formerly Sinclair IS Pharma plc, is a dermatology pharmaceutical company, which strives to provide dermatological solutions. The company develops, manufactures and distributes dermatology products for facial aesthetics, particularly for facial rejuvenation, through collagen stimulation. It also offers dermal fillers for folds and lines. Its major areas of focus include aesthetics, wound care, and skin care. Some of Sinclair's major brands include Silhouette Soft; Ellanse; Perfectha and Sculptra. The company has a presence in various countries through a network of subsidiaries. It has direct sales and marketing presence in five major European countries. It also has multi-product and multi-country distribution partnerships with several companies. Sinclair is headquartered in London, the UK.

Sinclair Pharma Plc (SPH)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Sinclair Pharma Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

Sinclair Pharma Plc, Medical Devices Deals, 2011 to YTD 2017 11

Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12

Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deal Details 14

Partnerships 14

Sinclair IS Pharma Enters Into Co-Promotion Agreement With Galderma For Kelo-cote 14

Sinclair Pharma Extends Co-Marketing Agreement With Invida 14

Helsinn Healthcare Enters Into Collaboration With IS Pharma 15

Merger 16

Sinclair Pharma Merges With IS Pharma To Form Sinclair IS Pharma 16

Licensing Agreements 18

Sinclair IS Pharma Enters Into Licensing Agreement With Hikma Pharma For Flammacerium 18

Sinclair IS Pharma Enters Into Licensing Agreement With Menarini Group For Three Products 19

Sinclair IS Pharma Enters Into Agreement With Biocodex For Dermatology Portfolio 19

Quintiles Enters Into Licensing Agreement With Sinclair IS Pharma 20

Sinclair IS Pharma Enters Into Licensing Agreement With Teva Pharma For episil 21

Helsinn Healthcare Enters Into Licensing Agreement With IS Pharma For NETU-PALO FDC 22

Equity Offering 23

Sinclair IS Pharma Announces Private Placement Of Shares For US$15 Million 23

Asset Transactions 24

Alliance Pharma Acquires Healthcare Products Business from Sinclair IS Pharma for USD198.4 Million 24

Bailleul Biorga And Hexim Pharma Acquire Non-Core Products From Sinclair IS Pharma For US$1.8 Million 25

Laboratoires SERB Acquires Mysoline from Sinclair IS Pharma for USD17.8 Million 26

Acquisition 27

Lupin May Acquire Sinclair IS Pharma for USD500 Million 27

Sinclair IS Pharma to Sell Itself 28

Sinclair Is Pharma Acquires Obvieline Labs From Pharmavital 28

Sinclair IS Pharma Completes Acquisition Of Advanced Bio-Technologies For US$33 Million 29

IS Pharma Completes Acquisition Of Helsinn Birex Therapeutics For US$5.7 Million 30

Sinclair Pharma Plc-Key Competitors 32

Key Employees 33

Locations And Subsidiaries 34

Head Office 34

Other Locations & Subsidiaries 34

Recent Developments 36

Financial Announcements 36

Mar 21, 2017: Sinclair Pharma Announces Preliminary results for the 12 and 18 months ended 31 December 2016 36

Jan 17, 2017: Sinclair Pharma Announces Pre-Close Trading Update 37

Sep 21, 2016: Sinclair Pharma: Second Interim Statement (Jan-Jun 2016) 38

Jul 18, 2016: Trading update and notification of board changes GBP17.2m revenue in 1H calendar 2016 39

Mar 30, 2016: Sinclair Pharma Announces Interm Results 41

Corporate Communications 42

Sep 01, 2016: Sinclair Pharma: Restructuring programme and Board change 42

Appendix 43

Methodology 43

About GlobalData 43

Contact Us 43

Disclaimer 43

List of Figures

Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7

Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

Sinclair Pharma Plc, Medical Devices Deals, 2011 to YTD 2017 11

List of Tables

Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Key Facts, 2016 1

Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Sinclair Pharma Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Sinclair Pharma Plc, Deals By Therapy Area, 2011 to YTD 2017 9

Sinclair Pharma Plc, Medical Devices Deals, 2011 to YTD 2017 11

Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12

Sinclair IS Pharma Enters Into Co-Promotion Agreement With Galderma For Kelo-cote 14

Sinclair Pharma Extends Co-Marketing Agreement With Invida 14

Helsinn Healthcare Enters Into Collaboration With IS Pharma 15

Sinclair Pharma Merges With IS Pharma To Form Sinclair IS Pharma 16

Sinclair IS Pharma Enters Into Licensing Agreement With Hikma Pharma For Flammacerium 18

Sinclair IS Pharma Enters Into Licensing Agreement With Menarini Group For Three Products 19

Sinclair IS Pharma Enters Into Agreement With Biocodex For Dermatology Portfolio 19

Quintiles Enters Into Licensing Agreement With Sinclair IS Pharma 20

Sinclair IS Pharma Enters Into Licensing Agreement With Teva Pharma For episil 21

Helsinn Healthcare Enters Into Licensing Agreement With IS Pharma For NETU-PALO FDC 22

Sinclair IS Pharma Announces Private Placement Of Shares For US$15 Million 23

Alliance Pharma Acquires Healthcare Products Business from Sinclair IS Pharma for USD198.4 Million 24

Bailleul Biorga And Hexim Pharma Acquire Non-Core Products From Sinclair IS Pharma For US$1.8 Million 25

Laboratoires SERB Acquires Mysoline from Sinclair IS Pharma for USD17.8 Million 26

Lupin May Acquire Sinclair IS Pharma for USD500 Million 27

Sinclair IS Pharma to Sell Itself 28

Sinclair Is Pharma Acquires Obvieline Labs From Pharmavital 28

Sinclair IS Pharma Completes Acquisition Of Advanced Bio-Technologies For US$33 Million 29

IS Pharma Completes Acquisition Of Helsinn Birex Therapeutics For US$5.7 Million 30

Sinclair Pharma Plc, Key Competitors 32

Sinclair Pharma Plc, Key Employees 33

Sinclair Pharma Plc, Subsidiaries 34

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Sinclair Pharma Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16020
Site License
USD 500 INR 32040
Corporate User License
USD 750 INR 48060

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com